Treatment of melasma with Jessner's solution versus glycolic acid: A comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination - 11/09/11
Abstract |
Background: Melasma can be resistant to topical therapy.
Objective: Our purpose was to evaluate the efficacy of superficial peels in conjunction with topical tretinoin and hydroquinone in patients with melasma and to evaluate the ability of Wood's light examination to predict response to treatment.
Methods: We measured increased light reflectance in melasma areas with a colorimeter. Clinical observations were scored through an index designed to weigh numerically homogeneity, intensity of color, and area of melasma.
Results: Colorimetric analysis showed an average lightening of 3.14 ± 3.1 on the glycolic acid–treated side and 2.96 ± 4.84 on the Jessner's solution–treated side. There was no statistically significant difference between the right and left. There was an overall decrease in melasma area and severity of 63%.
Conclusion: Superficial peels hasten the effects of topical therapy in melasma. Wood's light examination did not help predict response to treatment. (J Am Acad Dermatol 1997;36:589-93.)
Le texte complet de cet article est disponible en PDF.Plan
 | From the Department of Dermatologic Surgery, University of Dentistry and Medicine New Jersey Cooper Hospital/UMC,a the Cosmetic Surgery Center of North Carolina, University of North Carolina at Chapel Hill,b and the Department of Dermatology, Emory University School of Medicine, Atlanta.c |
| Reprint requests: Naomi Lawrence, MD, 8000 Sagemore Dr., Suite 8103, Marlton, NJ 08053. |
 | 0190-9622/97/$5.00 + 0 16/1/79205 |
Vol 36 - N° 4
P. 589-593 - avril 1997 Retour au numéro
Article précédent
- CD4 monoclonal antibody administration in atopic dermatitis
- Eric Robinet, Catherine Stamm, Jean-François Nicolas, Michel Faure, Alain Mercatello, Bernard Coronel, John Wijdenes, Jacques Bienvenu, Jean-Pierre Revillard, Alain Claudy
- Congenital erythropoietic porphyria
- Clemens Fritsch, Klaus Bolsen, Thomas Ruzicka, Günter Goerz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?